602 related articles for article (PubMed ID: 33115993)
1. [Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].
Hashimoto R; Ueda T; Tsuji Y; Otsuka Y; Sekiguchi K; Matsumoto R
Rinsho Shinkeigaku; 2020 Nov; 60(11):773-777. PubMed ID: 33115993
[TBL] [Abstract][Full Text] [Related]
2. [Atezolizumab-induced Guillain-Barré syndrome-like acute demyelinating polyneuropathy responsive to steroid therapy: a case report].
Yamanaka N; Oishi M; Shimizu F; Koga M; Kanda T
Rinsho Shinkeigaku; 2021 Oct; 61(10):653-657. PubMed ID: 34565748
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the Literature.
Janssen JBE; Leow TYS; Herbschleb KH; Gijtenbeek JMM; Boers-Sonderen MJ; Gerritsen WR; Westdorp H
J Immunother; 2021 Sep; 44(7):276-282. PubMed ID: 33758147
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
[TBL] [Abstract][Full Text] [Related]
6. [Successful corticosteroid therapies in a case of acute motor, sensory, autonomic neuropathy after cytomegalovirus infection].
Uchida Y; Koike H; Oguri T; Kato H; Yuasa H; Mitake S
Rinsho Shinkeigaku; 2015; 55(5):339-44. PubMed ID: 26028197
[TBL] [Abstract][Full Text] [Related]
7. [Case of a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without pharyngeal palsy].
Numata Y; Uematsu M; Hino-Fukuyo N; Kakisaka Y; Kobayashi T; Hirose M; Haginoya K; Tsuchiya S
No To Hattatsu; 2011 Nov; 43(6):482-5. PubMed ID: 22180965
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases.
Li Y; Zhang X; Zhao C
Biomed Res Int; 2021; 2021():9800488. PubMed ID: 34458371
[TBL] [Abstract][Full Text] [Related]
9. [Guillain-Barré syndrome following cytomegalovirus infection with increased level of antibody against moesin-a case report].
Shiga Y; Shimoe Y; Chigusa M; Kusunoki S; Mori M; Kuriyama M
Rinsho Shinkeigaku; 2018 Jun; 58(6):385-389. PubMed ID: 29863101
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature.
Ralapanawa U; Kumarihamy P; Jayalath T; Udupihille J
J Med Case Rep; 2019 Jul; 13(1):221. PubMed ID: 31324211
[TBL] [Abstract][Full Text] [Related]
11. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
[TBL] [Abstract][Full Text] [Related]
12. [A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer].
Yonenobu Y; Ishijima M; Toyooka K; Fujimura H
Rinsho Shinkeigaku; 2019 Feb; 59(2):105-108. PubMed ID: 30700688
[TBL] [Abstract][Full Text] [Related]
13. A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment.
Oguri T; Sasada S; Shimizu S; Shigematsu R; Tsuchiya Y; Ishioka K; Takahashi S; Oki K; Kimura Y; Seki R; Hirose S; Nakamura M
J Investig Med High Impact Case Rep; 2021; 9():23247096211037462. PubMed ID: 34344201
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy.
Koshikawa H; Tsukie T; Kurita A; Fujikura M; Suzuki M; Araki K
J Infect Chemother; 2017 Nov; 23(11):798-799. PubMed ID: 28506529
[TBL] [Abstract][Full Text] [Related]
15. [Co-existence of Guillain-Barré syndrome and Behcet syndrome: A case report].
Yu C; Li C; Fan YY; Xu Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1146-1149. PubMed ID: 33331329
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathy.
Arman Ç; Ibrahim K; Elif OK; Hacer D; Yeşim P
Ideggyogy Sz; 2023 Nov; 76(11-12):422-426. PubMed ID: 38051685
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
[TBL] [Abstract][Full Text] [Related]
18. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
Hayashi S; Nagamine S; Makioka K; Kusunoki S; Okamoto K
Rinsho Shinkeigaku; 2016 Sep; 56(9):593-9. PubMed ID: 27580763
[TBL] [Abstract][Full Text] [Related]
19. [Guillain-Barré syndrome associated with acute hepatitis A-A case report and literature review].
Saito A; Saito M; Shimoe Y; Yoshimoto T; Kawakami M; Okamoto H; Yoshikawa K; Kusunoki S; Kuriyama M
Rinsho Shinkeigaku; 2018 Sep; 58(9):574-577. PubMed ID: 30175808
[TBL] [Abstract][Full Text] [Related]
20. Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature.
Gravbrot N; Scherer K; Sundararajan S
Case Rep Oncol Med; 2019; 2019():5490707. PubMed ID: 31885974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
